Kanghong Pharmaceutical completes subsidiary absorption merger

Chengdu Kanghong Pharmaceutical Group announced its wholly-owned subsidiary Sichuan Jishengtang Pharmaceutical has completed the absorption merger of wholly-owned sub-subsidiary Sichuan Jishengtang Xingshang Biotechnology.

Following the merger, Jishengtang continues operations unchanged while Xingshang Biotechnology has been de-registered, with all assets, liabilities and business transferred.

The company said the move aims to improve operational efficiency, optimize resource allocation and reduce management costs. Other absorption mergers involving wholly-owned subsidiaries are currently in progress.